A. Gescher

813 total citations
33 papers, 670 citations indexed

About

A. Gescher is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, A. Gescher has authored 33 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in A. Gescher's work include Drug Transport and Resistance Mechanisms (5 papers), Chemical Reactions and Isotopes (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). A. Gescher is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Chemical Reactions and Isotopes (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). A. Gescher collaborates with scholars based in United Kingdom, Italy and Germany. A. Gescher's co-authors include W.P. Steward, Ricky A. Sharma, P. Kestell, J.K. Mellon, John A. Hickman, Ian L. Dale, T.R. Leyshon Griffiths, Michael D. Threadgill, B. C. Jones and Simon P. Langdon and has published in prestigious journals such as The Science of The Total Environment, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A. Gescher

31 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gescher United Kingdom 16 259 153 143 130 71 33 670
M. Margaret King United States 12 205 0.8× 85 0.6× 157 1.1× 122 0.9× 90 1.3× 21 648
P. Kestell New Zealand 16 357 1.4× 255 1.7× 183 1.3× 146 1.1× 49 0.7× 31 690
E Gravela Italy 14 272 1.1× 96 0.6× 239 1.7× 68 0.5× 72 1.0× 39 697
G J Mulder Netherlands 14 248 1.0× 227 1.5× 207 1.4× 53 0.4× 50 0.7× 29 723
Danuta Malejka‐Giganti United States 16 436 1.7× 94 0.6× 153 1.1× 188 1.4× 112 1.6× 65 776
Victor M. Samokyszyn United States 18 462 1.8× 111 0.7× 196 1.4× 87 0.7× 134 1.9× 32 1.0k
Jun-Yan Hong United States 14 325 1.3× 143 0.9× 336 2.3× 135 1.0× 66 0.9× 15 951
Donna Gilfor United States 15 528 2.0× 334 2.2× 216 1.5× 116 0.9× 52 0.7× 19 1.1k
Mi‐Sook Dong South Korea 18 386 1.5× 143 0.9× 367 2.6× 89 0.7× 60 0.8× 40 937
Stephen A. Lesko United States 16 461 1.8× 152 1.0× 103 0.7× 259 2.0× 229 3.2× 23 879

Countries citing papers authored by A. Gescher

Since Specialization
Citations

This map shows the geographic impact of A. Gescher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gescher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gescher more than expected).

Fields of papers citing papers by A. Gescher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gescher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gescher. The network helps show where A. Gescher may publish in the future.

Co-authorship network of co-authors of A. Gescher

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gescher. A scholar is included among the top collaborators of A. Gescher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gescher. A. Gescher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waring, R. H., Stephen D. Ayers, A. Gescher, et al.. (2007). Phytoestrogens and xenoestrogens: The contribution of diet and environment to endocrine disruption. The Journal of Steroid Biochemistry and Molecular Biology. 108(3-5). 213–220. 38 indexed citations
2.
Jain, Sunjay, et al.. (2007). A Review of Phase III Clinical Trials of Prostate Cancer Chemoprevention. Annals of The Royal College of Surgeons of England. 89(3). 207–211. 18 indexed citations
3.
Sharma, Ricky A., et al.. (2004). Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. European Journal of Cancer. 41(1). 61–70. 103 indexed citations
4.
Garcea, Giuseppe, et al.. (2004). Angiogenesis of gastrointestinal tumours and their metastases – a target for intervention?. European Journal of Cancer. 40(9). 1302–1313. 20 indexed citations
5.
Gescher, A., et al.. (2003). ErbB receptors: possible therapeutic targets in prostate cancer?. British Journal of Urology. 92(9). 890–895. 28 indexed citations
6.
Garcea, Giuseppe, Ricky A. Sharma, Ashley R. Dennison, et al.. (2003). Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention. European Journal of Cancer. 39(8). 1041–1052. 33 indexed citations
7.
Howard, Philip W., et al.. (1996). Interaction of the Pyrrolobenzodiazepine Antitumour Agent Anthramycin with Glutathione: A Possible Role in Metabolism. Pharmacy and Pharmacology Communications. 2(1). 39–42. 1 indexed citations
8.
Gescher, A. & Alberto Mantovani. (1994). Exploiting tumour biology: Novel approaches in cancer therapy. Annals of Oncology. 5(3). 205–207.
9.
Jones, B. C., et al.. (1994). Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.. Drug Metabolism and Disposition. 22(5). 806–810. 65 indexed citations
10.
Kainz, Alexander, et al.. (1992). Assessment of viability of hepatocytes in suspension using the MTT assay. Toxicology in Vitro. 6(6). 575–578. 39 indexed citations
11.
Mráz, Jaroslav, et al.. (1991). New findings in the metabolism of N,N-dimethylformamide — Consequences for evaluation of occupational risk. The Science of The Total Environment. 101(1-2). 131–134. 4 indexed citations
12.
Nicholls, D.J., A. Gescher, & Robert Griffin. (1991). Medicinal azides. Part 8. The in vitro metabolism of p-substituted phenyl azides. Xenobiotica. 21(7). 935–943. 12 indexed citations
13.
Bill, Colin A., A. Gescher, & John A. Hickman. (1988). Effects of N-methylformamide on the growth, cell cycle, and glutathione status of murine TLX5 lymphoma cells.. PubMed. 48(12). 3389–93. 16 indexed citations
14.
Kestell, P., et al.. (1987). An investigation of the relationship between the hepatotoxicity and the metabolism of N-alkylformamides.. Journal of Pharmacology and Experimental Therapeutics. 240(1). 265–270. 32 indexed citations
15.
Threadgill, Michael D., Donald B. Axworthy, Thomas A. Baillie, et al.. (1987). Metabolism of N-methylformamide in mice: primary kinetic deuterium isotope effect and identification of S-(N-methylcarbamoyl)glutathione as a metabolite.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 312–319. 34 indexed citations
16.
Gescher, A., Neil W. Gibson, John A. Hickman, et al.. (1982). N-methylformamide: Antitumour activity and metabolism in mice. British Journal of Cancer. 45(6). 843–850. 55 indexed citations
17.
Brindley, C., et al.. (1982). Studies of the pharmacology of N-methylformamide in mice.. PubMed. 66(11). 1957–65. 13 indexed citations
18.
Gescher, A. & A. Li Wan Po. (1978). Correlation of physicochemical properties with absorption and metabolism of some tricyclic drugs. Journal of Pharmacy and Pharmacology. 30(1). 353–358. 5 indexed citations
19.
Eckert, Elisabeth, M. Henseling, A. Gescher, & U. Trendelenburg. (1976). Stereoselectivity of the distribution of labelled noradrenaline in rabbit aortic strips after inhibition of the noradrenaline-metabolizing enzymes. Naunyn-Schmiedeberg s Archives of Pharmacology. 292(3). 219–229. 22 indexed citations
20.
Hoffmann, Hermann & A. Gescher. (1973). [The mechanism of the polarographic reduction of S,S-diphenylsulfoximines (author's transl)].. PubMed. 306(7). 492–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Margaret King Breakdown of academic impact, for papers by P. Kestell Breakdown of academic impact, for papers by E Gravela Breakdown of academic impact, for papers by G J Mulder Breakdown of academic impact, for papers by Danuta Malejka‐Giganti Breakdown of academic impact, for papers by Victor M. Samokyszyn Breakdown of academic impact, for papers by Jun-Yan Hong Breakdown of academic impact, for papers by Donna Gilfor Breakdown of academic impact, for papers by Mi‐Sook Dong Breakdown of academic impact, for papers by Stephen A. Lesko
Rankless by CCL
2026